Corgard is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Uswm, Llc. The primary component is Nadolol.
| Product ID | 78670-101_0581ffba-1535-47b5-b8b8-00570be4ef71 |
| NDC | 78670-101 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Corgard |
| Generic Name | Nadolol |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-11-18 |
| Marketing Category | NDA / |
| Application Number | NDA018063 |
| Labeler Name | USWM, LLC |
| Substance Name | NADOLOL |
| Active Ingredient Strength | 40 mg/1 |
| Pharm Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2021-11-18 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 27505-102 | Corgard | Corgard |
| 27505-100 | Corgard | Corgard |
| 27505-101 | Corgard | Corgard |
| 0093-4235 | Nadolol | Nadolol |
| 0093-4236 | Nadolol | Nadolol |
| 0093-4237 | Nadolol | Nadolol |
| 0378-0028 | Nadolol | nadolol |
| 0378-1132 | Nadolol | nadolol |
| 0378-1171 | Nadolol | nadolol |
| 0781-1181 | Nadolol | Nadolol |
| 0781-1182 | Nadolol | Nadolol |
| 0781-1183 | Nadolol | Nadolol |
| 0781-8004 | Nadolol | Nadolol |
| 0781-8005 | Nadolol | Nadolol |
| 0781-8006 | Nadolol | Nadolol |
| 0904-7070 | Nadolol | Nadolol |
| 0904-7071 | Nadolol | Nadolol |
| 10135-686 | Nadolol | Nadolol |
| 10135-687 | Nadolol | Nadolol |
| 10135-688 | Nadolol | Nadolol |
| 21695-799 | Nadolol | Nadolol |
| 21695-800 | Nadolol | Nadolol |
| 21695-802 | Nadolol | Nadolol |
| 23155-730 | Nadolol | Nadolol |
| 23155-731 | Nadolol | Nadolol |
| 23155-732 | Nadolol | Nadolol |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() CORGARD 73066843 1040408 Live/Registered |
E. R. SQUIBB & SONS, INC. 1975-10-23 |